Cargando…
Novel 3-phenylquinazolin-2,4(1H,3H)-diones as dual VEGFR-2/c-Met-TK inhibitors: design, synthesis, and biological evaluation
Multitarget anticancer drugs are more superior than single target drugs regarding patient compliance, drug adverse effects, drug-drug interactions, drug resistance as well as pharmaceutical industry economics. Dysregulation of both VEGFR-2 and c-Met tyrosine kinases (TKs) could result in development...
Autores principales: | Hassan, Abdelfattah, Mosallam, Ahmed M., Ibrahim, Amal O. A., Badr, Mohamed, Abdelmonsef, Aboubakr H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616113/ https://www.ncbi.nlm.nih.gov/pubmed/37903949 http://dx.doi.org/10.1038/s41598-023-45687-y |
Ejemplares similares
-
Design and biological evaluation of 3-substituted quinazoline-2,4(1H,3H)-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors
por: Hassan, Abdelfattah, et al.
Publicado: (2023) -
Novel Quinazolin-2,4-Dione Hybrid Molecules as Possible Inhibitors Against Malaria: Synthesis and in silico Molecular Docking Studies
por: Haredi Abdelmonsef, Aboubakr, et al.
Publicado: (2020) -
Synthesis, Characterization, Antibacterial Activity, and Computer-Aided Design of Novel Quinazolin-2,4-dione Derivatives as Potential Inhibitors Against Vibrio cholerae
por: El-Naggar, Mohamed, et al.
Publicado: (2020) -
Quinazoline-2,4(1H,3H)-dione
por: Liu, Ge
Publicado: (2008) -
2-(1,3-Benzodioxol-5-yl)-3-phenylquinazolin-4(3H)-one
por: Chandra,, et al.
Publicado: (2013)